Bio-Reference Labs (BRLI -0.6%) slips on a negative article from short-seller The Street...

Bio-Reference Labs (BRLI -0.6%) slips on a negative article from short-seller The Street Sweeper. The gist of the article says that the company is likely to be faced with a flood of denials from some of the largest health insurance companies in the country, and that growth projections are overly optimistic.

From other sites
Comments (3)
  • indianadan48
    , contributor
    Comments (79) | Send Message
    18 months ago street sweeper publ a neg article on BRLI calling it the MOB's Lab - This allowed a good entry pt at 12 and a monster gain when it was sold recently over 30. Thank-you street sweeper.
    Now if this can drop more then deserved could be a good buy in the MAY-June time period when the economy slows due to the 3 yes 3 tax increases put in by the socialists. Stock should shortly be earning close to $2.00 per share
    27 Feb 2013, 04:18 PM Reply Like
  • dook
    , contributor
    Comments (67) | Send Message
    BRLI's broad geographic coverage and focus on difficult lab solutions differentiates them from most other labs. Their growth outlook, in my opinion, is promising, and the valuation, low.
    Taking the advice of short sellers is usually counterproductive.
    27 Feb 2013, 04:28 PM Reply Like
  • ICT Optimist
    , contributor
    Comments (5) | Send Message
    If this goes lower it should be another buying opportunity. Last time they published their manifesto of old news I picked up shares @$12.10 and just recently sold half above $30.00. Can't see the institutions letting this go much lower as GARP isn't that easy to find.
    28 Feb 2013, 07:24 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs